Coloplast sales rise 20%, profits 61%
This article was originally published in Clinica
Executive Summary
Danish medical device manufacturer Coloplast reported sales up 20% in the six months to the end of March to DKr 936.9 million ($160 million). Excluding skincare products sales from US subsidiary Sween, which was acquired in early 1995, Coloplast's sales rose 13%. Pre-tax profit in the first six months was DKr 110 million, up 61%. The strongest sales growth was seen in woundcare, up 24%, followed by incontinence products, up 19%, and ostomy sales, up 13%. Sales of breast care products increased 8%. Coloplast has confirmed earlier forecasts of sales and profit growth of more than 15% during fiscal 1996.